Meta tags:
keywords=;
description=;

Headings (most frequently used words):

you, about, to, exit, abbott, website, investors, newsroom, responsibility, careers, press, releases, are, for, another, country, or, region, specific, do, wish, continue, and, this, subscribe, consumers, healthcare, professionals, partners, contact, site, map, policies, privacy, policy, terms, conditions,

Text of the page (most frequently used words):
and (44), the (43), #diabetes (40), abbott (36), with (33), dka (33), people (27), for (20), diabetic (17), #ketoacidosis (17), that (15), ketones (15), may (14), are (14), not (14), type (14), can (14), data (13), glucose (12), ketone (11), hospitalizations (10), care (10), libre (10), rising (8), from (8), loading (7), all (7), 2026 (7), which (7), early (7), blood (7), when (7), information (6), about (6), healthcare (6), more (6), our (6), 000 (6), monitoring (6), symptoms (6), many (6), levels (6), recognize (6), overview (6), site (5), medical (5), among (5), than (5), technology (5), living (5), help (5), develops (5), has (5), detect (5), new (5), findings (5), adults (5), show (5), professionals (5), you (4), this (4), website (4), have (4), countries (4), its (4), identify (4), privacy (4), health (4), hospital (4), diagnosis (4), https (4), important (4), continuous (4), across (4), their (4), study (4), releases (4), duo (4), yet (4), these (4), risk (4), better (4), while (4), often (4), hospitalization (4), events (4), press (4), responsibility (4), careers (4), faqs (4), please (3), other (3), products (3), use (3), company (3), policy (3), com (3), american (3), association (3), sick (3), severe (3), hypoglycemia (3), awareness (3), freestyle (3), safety (3), over (3), time (3), insights (3), insulin (3), systems (3), role (3), they (3), measure (3), provide (3), warning (3), before (3), fda (3), monitors (3), available (3), test (3), testing (3), lead (3), body (3), coma (3), death (3), both (3), earlier (3), remains (3), one (3), most (3), develop (3), common (3), pediatric (3), delays (3), related (3), children (3), admission (3), associated (3), rates (3), ada (3), scientific (3), sessions (3), share (3), content (3), contact (3), consumers (3), subscribe (3), exit (2), requested (2), country (2), region (2), result (2), devices (2), also (2), specific (2), product (2), trade (2), without (2), further (2), preferences (2), terms (2), conditions (2), policies (2), catherine (2), alston (2), michael (2), comilla (2), youth (2), claims (2), analysis (2), days (2), clinical (2), prevalence (2), costs (2), between (2), secondary (2), endocrinology (2), 2023 (2), org (2), open (2), research (2), only (2), www (2), facebook (2), linkedin (2), global (2), leader (2), helps (2), life (2), portfolio (2), leading (2), support (2), real (2), providing (2), into (2), how (2), food (2), make (2), progress (2), there (2), cgm (2), sensor (2), play (2), management (2), but (2), designed (2), always (2), developed (2), dual (2), sensing (2), urine (2), individuals (2), recognizing (2), action (2), enough (2), energy (2), starts (2), breaking (2), down (2), fat (2), called (2), dangerous (2), prompt (2), announced (2), day (2), said (2), still (2), signs (2), rise (2), need (2), sooner (2), reduce (2), stable (2), understand (2), importance (2), within (2), hours (2), growing (2), challenge (2), quickly (2), illnesses (2), recognition (2), close (2), showed (2), nearly (2), per (2), likely (2), increased (2), difficult (2), presented (2), multiple (2), studies (2), impact (2), june (2), jun (2), newsroom (2), investors (2), glance (2), heritage (2), who (2), search (2), jobs (2), conferences (2), benefits (2), culture (2), students (2), working (2), news (2), yes, wish, continue, aware, intended, residents, particular, noted, contain, pharmaceuticals, uses, those, approved, regions, optimized, your, screen, size, another, unless, otherwise, specified, service, names, appearing, internet, trademarks, owned, licensed, subsidiaries, affiliates, any, trademark, name, dress, made, prior, written, authorization, except, services, rights, reserved, read, legal, notice, details, submit, eventtype, pageurl, advertising, myabbott, consumer, media, financial, source, sherr, burden, planning, accessed, february, miller, characterizing, presentation, using, admitting, diagnoses, trends, galindo, mortality, differences, primary, dhatariya, lancet, 2025, hepprich, roser, stiebitz, felix, schultes, schmitz, rutishauser, schubert, aberle, rudofsky, knowledge, cross, sectional, multicenter, survey, e003662, file, based, number, patients, assigned, each, manufacturer, doi, 1136, bmjdrc, 003662, bmj, pubmed, ncbi, nlm, nih, gov, 41381175, getting, system, prescription, visit, html, connect, youtube, instagram, live, fully, stages, changing, technologies, spans, spectrum, businesses, diagnostics, nutritionals, branded, generic, medicines, 122, colleagues, serve, 160, continues, pioneer, groundbreaking, revolutionized, years, ago, world, today, used, million, see, numbers, activity, impacts, them, goals, full, partial, reimbursement, like, plus, because, key, driver, relying, alone, pending, clearance, monitor, prevent, offer, snapshot, depend, caregivers, deciding, check, regularly, lack, supplies, delay, participants, unnoticed, until, emergency, published, british, journal, occurs, doesn, get, acids, experience, dehydration, changes, potassium, electrolytes, treatment, what, frequently, asked, questions, alternative, existing, options, combines, single, daily, mark, filed, regulatory, submission, drug, administration, cleared, sale, united, states, clear, preventing, mahmood, kazemi, chief, officer, business, preventable, emergencies, too, miss, begin, underscore, ways, avoidable, cgms, essential, helping, manage, however, currently, even, appear, some, underused, visibility, potential, mimic, kurt, midyett, endocrinologist, saint, luke, specialists, kansas, city, misattributed, lengthy, costly, underscores, addressing, gaps, now, drives, majority, requiring, inpatient, lasting, week, costing, stay, separate, millions, indicate, underreported, diagnosed, after, condition, longer, stays, higher, reducing, improve, outcomes, ages, second, 200, 2017, 2024, approximately, cases, increase, was, pronounced, led, stayed, low, due, greater, less, curb, 100, found, person, first, arrives, such, nausea, fatigue, stomach, pain, overlap, confirmed, depends, tests, sugar, bicarbonate, immediately, highlight, approaches, timely, hard, admissions, analyzing, insurance, challenging, young, does, begins, causing, traditionally, increasingly, affecting, notes, high, escalate, left, untreated, aren, familiar, despite, guidance, recommending, during, periods, elevated, making, misunderstood, nyse, abt, revealing, undetected, concern, shared, 86th, sharp, increases, age, groups, nationwide, reinforces, advanced, significantly, opportunities, prnewswire, park, ill, routine, contribute, missed, intervention, easy, download, res, photos, twitter, back, map, partners, fund, sustainability, social, executive, team, experts, honors, contacts, governance, resources, stock, info, financials,

Text of the page (random words):
new abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis jun 6 2026 investors overview financials stock info resources news events governance newsroom news press releases press contacts honors experts executive team responsibility overview social impact sustainability abbott fund subscribe consumers consumers healthcare professionals healthcare professionals careers overview working with us professionals students our people and culture benefits faqs conferences events search jobs careers overview working with us professionals students our people and culture benefits faqs conferences events search jobs about abbott overview who we are our heritage abbott at a glance abbott faqs contact us responsibility subscribe about abbott overview who we are our heritage abbott at a glance abbott faqs contact us responsibility subscribe consumers healthcare professionals careers about abbott careers investors newsroom responsibility partners contact site map policies privacy policy terms conditions press releases back to press releases new abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis share content to facebook share content to linkedin share content to twitter photos 1 jun 6 2026 download hi res close diabetic ketoacidosis dka can develop quickly and is not always easy to detect early ketone monitoring is not yet routine in diabetes care which may contribute to missed warning signs of dka and delays in intervention nearly 60 of pediatric hospitalizations for type 1 diabetes in the u s are associated with dka 1 abbott park ill june 6 2026 prnewswire abbott nyse abt the global healthcare leader announced new data revealing diabetic ketoacidosis dka remains an important yet often undetected health concern for people living with both type 1 and type 2 diabetes findings from multiple abbott studies shared at the american diabetes association s ada june 2026 86th scientific sessions show sharp increases in dka related hospitalizations across all age groups nationwide the data reinforces that while diabetes technology has advanced significantly there are opportunities to better detect rising ketones before dka develops diabetic ketoacidosis often misunderstood and difficult to recognize dka develops in people with diabetes when the body does not have enough insulin and begins breaking down fat for energy causing ketones to rise to dangerous levels in the blood 2 while traditionally associated with type 1 diabetes dka is increasingly affecting people with type 2 diabetes the american diabetes association notes that high ketone levels can escalate to dka within hours and if left untreated can lead to coma or death 2 many people living with diabetes aren t familiar with dka or its symptoms despite clinical guidance recommending ketone testing during periods of elevated glucose making it a challenge to detect early new dka data from abbott presented at ada s scientific sessions at the ada s scientific sessions abbott presented findings from multiple studies analyzing hospitalization admission diagnosis and insurance claims data to better understand how dka may be challenging to identify its rising impact among young people and a growing prevalence in adults with type 2 diabetes dka may be hard to identify early at hospital admissions a study of over 100 000 people across the u s found that dka can be difficult to recognize when a person first arrives at the hospital as early symptoms such as nausea fatigue or stomach pain overlap with many common illnesses 3 a confirmed diagnosis of dka depends on blood tests that measure blood sugar blood ph and or bicarbonate levels and ketones which may not be immediately available at admission 2 these delays highlight the need for approaches to recognize dka earlier to provide timely care better awareness of dka may help curb hospitalizations a second study of over 200 000 people showed that between 2017 2024 dka hospitalization rates among people with type 1 diabetes increased approximately 24 rising from 50 to 62 cases per 1 000 individuals the increase was more pronounced in children than adults 4 most dka events led to hospitalization for both children and adults while severe hypoglycemia rates stayed low and stable likely due to greater recognition of hypoglycemia and less awareness of dka risk 4 reducing dka hospitalizations may improve health outcomes across all ages one analysis of close to 40 000 pediatric hospitalizations showed dka now drives nearly 60 of all diabetes related hospitalizations among youth with type 1 or type 2 diabetes 1 most u s hospitalizations among children with diabetes are related to dka with the majority requiring inpatient care lasting up to one week and costing up to 38 000 per stay 1 findings from a separate study with data from millions of people indicate dka is likely underreported in adults with type 2 diabetes and when diagnosed after admission as a secondary condition is associated with longer hospital stays higher costs and increased rates of death 5 these findings from abbott show that diabetic ketoacidosis remains a growing challenge to identify as dka can develop quickly and mimic common illnesses said kurt midyett m d pediatric endocrinologist at saint luke s endocrinology specialists in kansas city mo when early symptoms are misattributed delays in diagnosis are common and often result in lengthy and costly hospitalization this data underscores the importance of addressing gaps in recognition to help detect rising ketones before dka develops the role of ketone monitoring in diabetes care continuous glucose monitors cgms play an essential role in helping people manage their diabetes by providing real time glucose insights however they do not currently measure ketones and dka can still develop even when glucose levels appear stable 6 insights from adults living with type 1 diabetes show that while some people understand the importance of monitoring ketones testing is often underused rising ketones can progress to dka within hours so earlier visibility has the potential to prompt action sooner and reduce risk 6 these new data make clear that preventing diabetic ketoacidosis starts with recognizing risk earlier said mahmood kazemi m d chief medical officer for abbott s diabetes care business dka remains one of the most preventable emergencies in diabetes care yet too many people still miss early warning signs when ketones levels begin to rise these findings underscore the need for better ways to recognize risk sooner and help reduce avoidable hospitalizations as an alternative to existing ketone monitoring options abbott has developed dual glucose ketone sensing technology which combines continuous glucose and ketone monitoring in a single sensor designed to support both daily diabetes management and help to detect rising ketone levels for people living with diabetes abbott announced ce mark for the systems called libre duo and libre duo 10 day in may 2026 the company has also filed a regulatory submission with the u s food drug administration fda libre duo and libre duo 10 day systems are not yet cleared by the fda or available for sale in the united states frequently asked questions what is diabetic ketoacidosis diabetic ketoacidosis dka occurs when the body doesn t have enough insulin to get energy the body starts breaking down fat which releases acids called ketones into the blood people in dka can experience severe dehydration dangerous changes to potassium and other electrolytes and coma without prompt treatment dka can lead to coma or death can people use urine and blood ketone monitors to test ketones urine and blood ketone monitors are available but they only offer a snapshot in time and depend on individuals or caregivers recognizing symptoms and deciding to test many do not check ketones regularly or lack testing supplies which can delay action in a study published in the british medical journal open diabetes research care 64 of participants do not test for ketones at all which can lead to rising ketones that may go unnoticed until a medical emergency develops 7 can a continuous glucose monitor cgm provide information that helps prevent diabetic ketoacidosis a cgm like the freestyle libre 3 plus sensor can play an important role in diabetes management but they are not designed to measure ketones because rising ketones are a key driver of diabetic ketoacidosis relying on glucose data alone may not always provide an early warning before diabetic ketoacidosis dka develops abbott has developed a dual glucose ketone sensing technology in the u s that is pending fda clearance about libre abbott continues to pioneer groundbreaking technology to support people living with diabetes the company revolutionized diabetes care more than 10 years ago with its world leading libre continuous glucose monitoring portfolio 8 which today is used by more than 8 million people across over 60 countries people use libre technology to see their glucose numbers in real time providing insights into how food activity or insulin impacts their glucose to help them make progress on their health goals there is full or partial reimbursement for libre systems in more than 40 countries 8 about abbott abbott is a global healthcare leader that helps people live more fully at all stages of life our portfolio of life changing technologies spans the spectrum of healthcare with leading businesses and products in diagnostics medical devices nutritionals and branded generic medicines our 122 000 colleagues serve people in more than 160 countries connect with us at www abbott com and on linkedin facebook instagram x and youtube important safety information freestyle libre 3 system is for prescription only for important safety information please visit https www freestyle abbott us en safety information html 1 sherr et al burden of diabetic ketoacidosis among youth with diabetes a hospital claims analysis 2 american diabetes association planning for sick days accessed february 6 2026 https diabetes org getting sick with diabetes sick days 3 miller et al characterizing the clinical presentation of diabetic ketoacidosis hospitalizations in people with diabetes using admitting diagnoses 4 trends in the prevalence of diabetic ketoacidosis and severe hypoglycemia in type 1 diabetes 5 galindo et al mortality and costs of diabetic ketoacidosis hospitalizations in people with type 2 diabetes differences between primary vs secondary diagnosis 6 dhatariya et al lancet diabetes endocrinology 2025 https pubmed ncbi nlm nih gov 41381175 7 hepprich m roser p stiebitz s felix b schultes b schmitz d rutishauser j schubert s aberle j rudofsky g 2023 awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes a cross sectional multicenter survey bmj open diabetes research care 11 6 e003662 https doi org 10 1136 bmjdrc 2023 003662 8 data on file abbott diabetes care data based on the number of patients assigned to each manufacturer source abbott for further information abbott media catherine alston catherine alston abbott com abbott financial michael comilla michael comilla abbott com policies terms conditions privacy policy consumer health data privacy policy myabbott privacy preferences advertising preferences pageurl eventtype submit 2026 abbott all rights reserved please read the legal notice for further details unless otherwise specified all product and service names appearing in this internet site are trademarks owned by or licensed to abbott its subsidiaries or affiliates no use of any abbott trademark trade name or trade dress in this site may be made without the prior written authorization of abbott except to identify the product or services of the company you are about to exit for another abbott country or region specific website please be aware that the website you have requested is intended for the residents of a particular country or region as noted on that site as a result the site may contain information on pharmaceuticals medical devices and other products or uses of those products that are not approved in other countries or regions the website you have requested also may not be optimized for your specific screen size do you wish to continue and exit this website yes no loading loading loading loading loading loading loading